NeuroBionics

NeuroBionics is a biotechnology startup based in Boston, founded in 2023.

The company focuses on precision bioelectronic medicine by developing minimally-invasive, implantable neural interface devices. These devices are designed to integrate seamlessly with the human body, advancing human health through innovative neuromodulation therapies. The core technology, known as evStim, features hair-thin, flexible bioelectronic fibers that support electrical, optical, and chemical recording and stimulation. This technology allows for precise therapeutic interventions in deep brain regions without the need for open surgery, using an endovascular approach to navigate through blood vessels. NeuroBionics aims to treat conditions such as Parkinson’s disease, epilepsy, and depression, as well as peripheral nervous system disorders. With approximately 10 employees, NeuroBionics has raised $5.08 million in funding, led by Dolby Family Ventures. The company is committed to making neuromodulation therapies more accessible and less invasive, ultimately benefiting millions of patients facing neurological challenges.